Medikamentenvergleiche
Semaglutide vs. Rosiglitazone
Compare Semaglutide (Ozempic/Rybelsus) vs Rosiglitazone (Avandia) for type 2 diabetes: efficacy, weight effects, CV safety, and black-box warnings.
Für diese Seite sind keine Vergleichsdimensionen verfügbar.
Klinischer Kontext
Triggered when a patient on a thiazolidinedione seeks greater glycemic control, weight loss, or cardiovascular protection and is considering a switch to a GLP-1 receptor agonist.
Fazit
Semaglutide typically outperforms Rosiglitazone on glucose lowering, weight, and CV outcomes, yet both require individualized safety evaluation.
Alle Medikamentenvergleiche